Vidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849.
Thompson, A J
Vidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849. [electronic resource] - Journal of viral hepatitis 11 2016 - 838-839 p. digital
Publication Type: Editorial; Comment
1365-2893
10.1111/jvh.12570 doi
Antiviral Agents
Drug Resistance--drug effects
Drug Resistance, Viral--drug effects
Genotype
Hepacivirus--drug effects
Hepatitis C
Humans
Peptide Hydrolases--genetics
Protease Inhibitors
Viral Nonstructural Proteins--genetics
Vidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849. [electronic resource] - Journal of viral hepatitis 11 2016 - 838-839 p. digital
Publication Type: Editorial; Comment
1365-2893
10.1111/jvh.12570 doi
Antiviral Agents
Drug Resistance--drug effects
Drug Resistance, Viral--drug effects
Genotype
Hepacivirus--drug effects
Hepatitis C
Humans
Peptide Hydrolases--genetics
Protease Inhibitors
Viral Nonstructural Proteins--genetics